Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-AG-18-014

Limited Competition: Data Coordinating Center for the Accelerating Medicines Partnership Target Discovery and Preclinical Validation Consortium AMP-AD DCC (U24 Clinical Trial Not Allowed)

Closed on February 20, 2018.

Posted
September 27, 2017
Close date
February 20, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,284,372 in first-year total cost, median $1,284,372.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-6 (A1)]1

Most frequent institutions

  1. SAGE BIONETWORKS1
Competing awards under RFA-AG-18-014 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018AMP-AD Data Coordination Center1U24AG061340-01MANGRAVITE, LARA MSAGE BIONETWORKS, WA$1,284,372ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-AG-18-014: Limited Competition: Data Coordinating Center for the Accelerating Medicines Partnership Target Discovery and Preclinical Validation Consortium AMP-AD DCC (U24 Clinical Trial Not Allowed) | ScienceDex | ConductScience